ArticlePDF Available

Abstract

Poor sleep imparts a significant personal and societal burden. Therefore, it is important to have accurate estimates of its causes, prevalence and costs to inform health policy. A recent evaluation of the sleep habits of Australians demonstrates that frequent (daily or near daily) sleep difficulties (initiating and maintaining sleep, and experiencing inadequate sleep), daytime fatigue, sleepiness and irritability are highly prevalent (20%-35%). These difficulties are generally more prevalent among females, with the exception of snoring and related difficulties. While about half of these problems are likely to be attributable to specific sleep disorders, the balance appears attributable to poor sleep habits or choices to limit sleep opportunity. Study of the economic impact of sleep disorders demonstrates financial costs to Australia of $5.1 billion per year. This comprises $270 million for health care costs for the conditions themselves, $540 million for care of associated medical conditions attributable to sleep disorders, and about $4.3 billion largely attributable to associated productivity losses and non-medical costs resulting from sleep loss-related accidents. Loss of life quality added a substantial further non-financial cost. While large, these costs were for sleep disorders alone. Additional costs relating to inadequate sleep from poor sleep habits in people without sleep disorders were not considered. Based on the high prevalence of such problems and the known impacts of sleep loss in all its forms on health, productivity and safety, it is likely that these poor sleep habits would add substantially to the costs from sleep disorders alone.
Sleep disorders
S7MJA 199 (8) · 21 October 2013
The Medical Journal of Australia ISSN: 0025-
729X 21 October 2013 199 8 7-10
©The Medical Journal of Australia 2013
www.mja.com.au
Supplement
leep is a basic and necessary biological process that
demands to be satisfied as much as our need for
food and drink. Inadequate sleep can occur if insuf-
ficient time is allowed for it or if a disorder is present that
disturbs sleep quality. It is only recently that we have
begun to understand the scale of the health and social
consequences of insufficient sleep and sleep disorders.
Sleep loss from these problems is associated with distur-
bances in cognitive and psychomotor function including
mood, thinking, concentration, memory, learning, vigi-
lance and reaction times.1,2 These disturbances have
adverse effects on wellbeing, productivity and safety.
Insufficient sleep is a direct contributor to injury and death
from motor vehicle and workplace accidents.3 Further,
relationships have been demonstrated between shortened
sleep and a range of health problems including hyperten-
sion,4 type 2 diabetes,5 obesity,6 cardiovascular disease7,8
and total mortality risk.9 Specific sleep disorders such as
insomnia,10 obstructive sleep apnoea (OSA)11 and restless
leg syndrome12 have also been associated with increased
morbidity and mortality. These sleep-related problems
incur financial costs relating to health and other expendi-
tures and non-financial costs relating to loss of quality of
life. This article considers the prevalence and economic
impacts of sleep problems in Australia.
Prevalence of sleep problems
There have been very few studies of the prevalence of
disturbed sleep in Australia. A small survey (n=216) of
sleeping difficulties, daytime sleepiness and hypnotic
medication use was conducted in Adelaide more than 20
years ago.13 A larger survey (n= 535) was conducted in
Newcastle, New South Wales, in 1996 but was limited to a
question about insomnia and hypnotic medications.14
Another small survey (n= 267) in rural Victoria among
Australian day workers was heavily weighted to men.15
More recently, a large NSW mail survey (n= 3300) reported
that 18.4% of participants slept less than 6.5 hours a night
and 11.7% complained of chronic sleepiness.16 A recent
study of the insomnia burden suggested a prevalence of
5.6%, with increased use of health care.17
To further characterise sleep quality in a large represent-
ative sample of Australians, in 2010, the Sleep Health
Foundation (www.sleephealthfoundation.org.au) commis-
sioned a national survey of sleeping difficulties and nega-
tive daytime consequences of poor sleep. It was modelled
on the Sleep in America surveys conducted by the National
Sleep Foundation, in part to allow international compari-
sons. A national polling organisation (Roy Morgan
Research) was commissioned to perform the work. It
conducted a national landline telephone survey of adoles-
cents and adults (14 to > 70 years of age) across successive
weekend evenings. The survey contained 14 questions
about sleep: five about sleeping difficulty, two about snor-
ing and OSA, one about restless legs, one about sleeping
medication, three about daytime impairments usually
associated with sleep disturbance, and two about noctur-
nal sleep duration (weekdays and weekends) (Box 1).
There were 1512 respondents from all states and ter-
ritories, both urban and rural, with sampling proportionate
to the populations of those areas, sex and age.
Box 1 shows the proportions of respondents reporting
current sleep difficulties and daytime impairments at least
a few times per week (indicative of significant problem), as
well as average self-reported sleep duration for the popu-
lation overall, for males and females, and for each age
group. The results illustrate that a considerable proportion
of Australians report frequent sleeping difficulties. Overall,
20% of respondents had frequent difficulty falling asleep,
which was more prevalent among females and younger
age groups. Frequent waking during the night was
reported by 35% overall, again more commonly among
females but increasing with age. Thirty-five per cent
reported waking unrefreshed and 24% reported inade-
quate sleep. Daytime sleepiness, fatigue/exhaustion and
irritability were common issues (19%–24%).
Symptoms were examined to determine likely pre-
valence of insomnia by selecting those with specific self-
Public health implications of sleep loss:
the community burden
S
David R Hillman
MB BS, FANZCA, FRCPE,
Sleep Physician1
Leon C Lack
PhD,
Professor of Psychology2
1 Department of Pulmonary
Physiology and Sleep
Medicine, Sir Charles
Gairdner Hospital,
Perth , WA.
2 School of Psychology,
Flinders University,
Adelaide, S A.
David.Hillman@
health.wa.gov.au
MJA 2013; 199: S7–S10
doi: 10.5694/mja13.10620
Poor sleep imparts a significant personal and societal
burden. Therefore, it is important to have accurate
estimates of its causes, prevalence and c osts to inform
health policy.
A recen t evaluation of the sleep habits of Australi ans
demonstrates that freque nt (daily or near daily) sleep
difficulties (initiating and maintaining sleep, and
experiencing inadequate sleep), daytime fatigue,
sleepiness and irritability are highly prevalent (20%–
35%). These difficulties are gene rally more prevalent
among females, with the exception of snoring and
related difficulties. While about half of these problems
are likely to be attributable to specific sleep disorders, the
balance appears attributable to poor sleep habits or
choices to limit sleep opportunity.
Study of the economic impact of sleep disorders
demonstrates financial costs to Australia of $5.1 billion
per year. This comprises $270 million for health care
costs f or the con ditions them selves, $5 40 millio n for care
of associated medical conditions attribu table to sleep
disorders, and about $4.3 billion largely attributable to
associated productivity losses and non- medical costs
resulting from sleep loss-related accidents. Loss of life
quality added a subs tantial further non-financial cost.
While large, these costs were for sleep disorders alone.
Additional costs rel ating to inadequate sleep from poor
sleep habits in people without sleep disorders were not
considered. Ba sed on the high prevalence of such
problems and the known impacts of sleep loss in all its
forms on health, producti vity and safety, it i s likely th at
these poor sleep habits would add substantially to the
costs from sleep disorders alone.
Summary
Online first 17/10/13
MJA 199 (8 ) · 21 October 2013S8
Supplement
reported sleep difficulties plus daytime impairment18 to
derive a score that very closely simulates the Insomnia
Severity Index, a highly reliable and valid tool to identify
clinical insomnia.19 This suggested an overall presence of
severe insomnia (Insomnia Severity Index, > 14) of 6.9%,
8.7% in women and 5% in men (Box 1).
Prevalence of sleep apnoea was derived by determining
the proportion of respondents who snored loudly at least a
few times a week and had observed breathing pauses
during sleep at least a few times a month. An overall
prevalence of 4.9% was noted, but in this case, prevalence
was higher among males (6.4%) than females (3.6%).
While these prevalences of specific sleep disorders were
derived from combinations of questionnaire responses,
they are similar to the prevalences determined from other
population-based studies.10,20 These findings suggest that
specific sleep disorders may account for about half of the
complaints of daytime sleepiness and fatigue and exhaus-
tion noted in our survey. While other health problems can
disturb sleep, particularly in older patients, much of the
balance may be due to insufficient sleep duration by choice
or through circumstances that result in sleep being given a
lower priority than work, social or family activities. Sleep
duration estimates are significantly below the putative
average adolescent sleep requirement of 9 hours a night
and adult sleep requirement of 7.5–8 hours a night for both
men and women, particularly among those between the
ages of 35 and 65 years.21 Insufficient sleep at least a few
times a week was reported by 23.7% of the sample, more
frequently by females, and more commonly in the younger
to middle-aged groups. Perhaps relevant to this, a study of
young adults has shown that those with shorter habitual
sleep patterns carried the highest sleep debt, suggesting
self-selected sleep restriction.22
The general point that emerges from these data is that
inadequate sleep (duration or quality) and its daytime
consequences are widely prevalent in Australians, either
because of a specific sleep-related disorder or from volun-
tarily shortened sleep through choice or circumstance.
Although there are limitations with telephone surveys (eg,
low response rates to landline phone calls), the results are
very comparable with those observed in similar surveys
conducted elsewhere, such as the 2008 Centers for Disease
Control and Prevention study, which reported that 28% of
United States adults had insufficient sleep or rest (< 7 h/
night) on most nights over a 30-day survey period.23
Economic impact
Poor sleep and its consequences result in significant costs
to the community. Although there have been no detailed
economic evaluations of the costs associated with insuffi-
cient sleep in otherwise healthy individuals, analyses have
been undertaken for those with sleep disorders.24,25 OSA
provides an example of a widely prevalent sleep disorder
with significant comorbidities, including impaired daytime
alertness, increased accident risk, hypertension, vascular
1 Proportions of survey respondents experiencing sleep difficulties, sleep disorder symptoms and daytime impairments a few times a week or more
(often), overall and by sex and age group
Sex Age group
Difficulty experienced often Overall Male Female 14–17 years 18–24 years 25–34 years 35–49 years 50–64 years 65 years
Weighted proportion of total 100% 49.4% 50.6% 6.4% 11.7% 17.4% 26.0% 21.9% 16.5%
Sleeping difficulty
Difficulty falling asleep 19.6% 16.9% 22.4%* 33.6 %32.2%17.6% 20.0% 14.6% 13.5%
Waking a lot during night 34.9% 3 0.4% 39.3%21.2% 28.1% 32.6% 42.6%31.8% 39.5%
Waki ng up too e arly 25.3% 22.9% 27.7%* 19.5% 23.4% 20.3% 29.1%* 25.5% 27.9%*
Waki ng feelin g unre fre shed 34.7% 31.8% 37.6%* 38.1%44.0%42.0%39.8% 28.5% 19.3%
Did not get adequate sleep 23.7% 17.9% 29.4%24.9%29.3 %25.3%24.5%21.4% 19.3%
Snoring, obstructed breathing
Frequent or loud snoring21.2% 26.4%12.1% 8.4% 8.6% 21.7%23.5%20.0%20.0%
Pauses in breathing in sleep6.6% 6.2% 5.1% 2.9% 4.4% 3.8% 4.6% 7. 8%* 8.4%*
Restless legs 9.4% 8.6% 10.3% 4.0% 5.3% 11.2%7.2% 10.7 %14.5%
Prescribed sleep medication use 3.6% 4.0% 3.1% 3.5% 2.5% 1.8% 2.4% 5.8%5.4%
Daytime symptoms
Daytime sleepiness 19.0% 15.7% 22.3% * 24.6%26.2%21.1%22.4%13.6% 11.4%
Fatigue or exhaustion 23.5% 20.0% 27.0%22.8% 27.7%27.7%29.1%18.8% 14.2%
Irritable or moody 18.8% 18.2% 19.3% 18.8% 19.2% 27.9%22.9%12.9% 9.8%
Sleep duration
Weeknights (Sunday–Thursday), h 7.16 7.1 5 7.1 7 8.247.49 * 7.1 8 6.86 7.01 7. 14 *
Weekend n igh ts (Friday, Sa turday ), h 7.37 7. 3 7 7. 37 8.457.3 7 7.5 4 7.19 7.29 7. 14
Overall, h 7.2 2 7. 2 1 7. 23 8.307.4 6* 7.2 8 6.95 7.09 7.1 4 *
Sleep disorder estimates
Severe clin ical ins omni a§6.9% 5.0% 8.7%* 2 .0% 11.3 %* 4.2% 10.1%* 6.9% 3.8%
Sleep apnoea‡,¶ 4.9% 6.3%* 3.6% 0 2.2% 2.1% 4.7% 7.7%* 7.0%*
* P<0.05. †P<0.001. ‡ Adjusted for the 10%–11% who “can't say”. § Estimated Insomnia Severity Index > 14, derived from data for sleeping diculty and daytime symptoms.
¶ Estimates derived from data for frequent breathing pauses and loud snoring.
Sleep disorders
S9MJA 199 (8) · 21 October 2013
disease and depression.20 The associated costs include the
direct care-related health costs of the sleep disorder itself
and the costs of medical conditions occurring as a result of
them. In addition, there are substantial indirect financial
and non-financial costs. Other financial costs include the
non-health costs of work-related injuries, motor vehicle
accidents and productivity losses — all common conse-
quences of insufficient sleep. Non-financial costs derive
from loss of quality of life and premature death.24
In 2011, the Sleep Health Foundation commissioned
Deloitte Access Economics, a national economics consul-
tancy with a strong health economics background, to
undertake an analysis of the direct and indirect costs
associated with sleep disorders for the 2010 calendar
year.25 The methods used were similar to those that they
had used in a previous evaluation.24 Such an analysis
requires robust data relating to the prevalence of the sleep
disorder under consideration, the prevalences and costs
associated with conditions with which it has a causal
relationship, and the risk ratios describing the strength of
these relationships. Using these data, the proportion of
each condition attributable to the sleep disorder (the
attributable fraction) can be derived. Specifying the preva-
lences and odds ratios used to calculate attributable frac-
tions imparts transparency to the assumptions involved in
calculating them. The fraction can then be used to derive
the share of the costs associated with that condition that is
attributable to the particular sleep disorder under consid-
eration. Using these methods, Deloitte Access Economics
examined costs associated with the three most common
sleep disorders — OSA, primary insomnia and restless legs
syndrome — as the robust data required for analysis were
available.25 It estimated total health care costs of $818
million per year for these conditions, comprising $274
million for the costs of caring for the disorders themselves
and $544 million for conditions associated with them. Of
these costs, $657 million per year related to OSA: $248
million for OSA itself and $409 million for the health costs
of conditions attributable to OSA. These conditions
include hypertension, vascular disease, depression, and
motor vehicle and workplace accidents. The analysis sug-
gested that 10.1% of depression, 5.3% of stroke, 4.5% of
workplace injuries and 4.3% of motor vehicle accidents are
attributable to a sleep disorder.
The indirect financial and non-financial costs associated
with sleep disorders are much greater than the direct costs.
The indirect financial costs were estimated to be $4.3
billion in 2010. These included $3.1 billion in lost produc-
tivity and $650 million in informal care and other indirect
costs resulting from motor vehicle and workplace acci-
dents. Of these indirect costs, OSA accounted for 61%
($2.6 billion), primary insomnia for 36% ($1.5 billion) and
restless leg syndrome for 3% ($115 million).
The report also estimated the effect of sleep disorders on
loss of quality of life in terms of disability-adjusted life-
years. These costs were calculated using the proportion of
total national health costs attributable to sleep disorders to
proxy the proportionality of the total national disease
burden attributable to these problems. A dollar cost was
calculated from the product of these years lost (190 000)
and the value of a statistical life-year ($165 000). This
added a further non-financial cost of $31.4 billion to the
total economic cost of sleep disorders (Box 2). The non-
financial nature of this cost gave it less tangibility than
financial costs, but the calculation does draw attention to
the substantial burden associated with the loss of quality of
life resulting from sleep disorders.
As large as they are, these costs are likely to significantly
underestimate the total cost to the community of sleep-
related problems. Deloitte Access Economics evaluated
costs associated with common sleep disorders. The costs of
accidents and illnesses associated with sleep loss resulting
from poor sleep habits from personal choice and/or from
conflicting priorities such as work, social or family activities
were not considered as they are difficult to estimate.
Further, the analysis used conservative estimates of the
prevalence of sleep disorders. For example, the base preva-
lence of OSA used was 4.7%, which is below the propor-
tion of moderate OSA observed in many contemporary
studies, a proportion which is likely to increase further as
the population ages and becomes more obese.20 The
prevalence of insomnia used in the analysis was also low at
3%, a figure based on primary insomnia estimates.26 Sec-
ondary insomnias resulting from other causes were not
considered. Our own estimate including all insomnia from
a representative Australian sample (Box 1) was closer to
7%. Potential comorbidities of sleep disorders, even if
reasonable evidence for an association existed (such as
metabolic disorders in the case of OSA), were also
excluded from consideration. Finally, the analysis did not
cost some aspects of the known comorbidities of sleep
disorders, such as the impact of presenteeism (being
present at work but operating suboptimally) on productiv-
ity and safety. The reason for this omission was the
difficulty in reliably quantifying its effects.
Conclusion
Poor or inadequate sleep is very common among Austral-
ian adolescents and adults, affecting over 20% on a daily or
near-daily basis. Epidemiological studies suggest about
2 Summary of the annual costs of sleep disorders and
associated conditions, 201021
Varia bl e AUD (mil lion)
Direct health care co st
Sleep disorders 274
Associated conditions* 544
Indirect fina ncial cost
Productivity 3132
Informal care for accident victims 129
Other cost of mot or vehicle a ccidents 465
Other cost of workplace acc idents 53
Deadweight loss to taxation system 472
Tot al fi na nc ia l co st 5069
Non-financial cost
Loss of disab ility-adj usted life-years 31 350
Total economic co st 36 419
* Hypert ension, v ascular dis ease, depr ession, motor vehi cle injur ies and
workplace injuries.
MJA 199 (8 ) · 21 October 2013S10
Supplement
half of this problem can be attributable to common sleep
disorders such as OSA and insomnia, as together they
affect about 10% of the community. The balance appears
likely to be the result of inadequate sleep arising from
other health problems or issues such as poor sleep habits
or sleep loss because of competing demands on time from
work, social or family activities. Economic estimates dem-
onstrate that sleep disorders are associated with large
financial and non-financial costs. Given that the greatest
financial costs appear to be non-medical costs related to
loss of productivity and accident risk, it is likely that
inclusion of the effects of sleep restriction from poor sleep
habits or choice could add considerably to these already
substantial amounts.
Competing interests: No r elevant disclosu res.
Provena nce: Commissioned by supplement editors; externally peer reviewed.
1Institute of Medicine (US) Committee on Sleep Medicine and Research; Colten
HR, Altevogt BM, editors. Sleep disorders and sleep deprivation: an unmet
public health problem. Wa shington, DC: The National Academies Press, 2006.
2Dinges DF, Pack F, Williams K, et al. Cumulati ve sleepiness, mood disturbance,
and psychomotor vigilance performance decrements during a week of sleep
restricted to 4 -5 hours per ni ght. Sleep 1997; 20: 267-277.
3Stutts JC, Wilkins JW, Scott Osberg J, Vaughn BV. Driver risk factors for sleep-
related crashes. Acc id An al Pre v 2003; 35: 321-331.
4Vgontzas AN, Liao D, Bixler EO, et al. Insomnia with objective short sleep
duration is a ssociated with a h igh risk for hyperten sion. Sleep 2009; 32:
491-497.
5Spiegel K, Knutso n K, Leproult R, et al. Sleep loss: a no vel risk factor for insuli n
resistance and type 2 diabetes. J Appl Physiol 2005; 99: 2008-2019.
6Watanabe M, Kikuchi H, Tanaka K, Takahashi M. A ssociation of sho rt sleep
duration with weight gain and obesity at 1-year follow-up: a large-scale
prospective study. Sleep 2010; 33: 161-167.
7Sabanayagam C, Shankar A. Sleep duration and cardiovascular disease: results
from the National H ealth Interview Survey. Sleep 2010; 3 3: 1037-104 2.
8Bagai K. Obst ructive sleep apnea , stroke, and cardiovascul ar diseases.
Neurologist 2010; 16: 329-339.
9Grandner MA, Hale L, Moore M, Patel NP. Mortality associated with short sleep
duration: the evidence, the p ossible mechani sms, and the future. Sleep M ed
Rev 2009; 14: 191-203.
10 Léger D, Guilleminault C, Bader G, et al. Medical and socio-professional impact
of insomnia. Sleep 2002; 25: 625-629.
11 Bagai K. Obst ructive sleep apnea , stroke, and cardiovascul ar diseases.
Neurologist 2010; 16: 329-339.
12 Garcia-Borre guero D, Egatz R, Win kelmann J, Berger K. Epidemiology of
restless legs synd rome: the current sta tus. Sleep Med Rev 200 6; 10: 153-167.
13 Lack L, Miller W, Turner DA. A survey of sleeping difficulties in an Australian
population. Community Health Stud 1988; 12: 2 00-207.
14 Olson LG. A community survey of insomnia in Newcastle. Aust N Z J P ublic
Health 1996; 20: 655-657.
15 Johns M, Ho cking B. Daytime slee piness and sleep habits of Australia n workers.
Sleep 1997; 20: 844-849.
16 Bartlett DJ, Marshall NS, Williams A, Grunstein RR. Sleep health New South
Wales: chronic sleep restriction and daytime sleepiness. Intern Med J 2008; 38:
24-31.
17 Bin YS, Marshall NS, Glozier N. The burden of insomnia on individual function
and healthcare consumption in Australia. Aust N Z J Public Health 2012; 36 :
462-468.
18 National Institutes of Health. NIH State of the Science Conference statement
on manifestations and management of chronic insomnia in adults, June 13-15,
2005. Sleep 2005; 28: 1049-1057.
19 Bastien CH, Vallieres A, Morin CM. Validation of the Insomnia Severity Index as
an outcome meas ure for insom nia research. Sleep Med 2001; 2: 297-307.
20 Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a
population health perspective. Am J Respir Crit Ca re Med 2002; 165: 12 17-1239.
21 Krueger PM, Friedman EM. Sleep duration in the United States: a cross-
sectional population-based study. Am J Epidemiol 2009; 169: 1052-1 063.
22 Klerman EB, Dijk D-B. Interindividual variation in sleep duration and its
association with sleep debt in young adults. Sleep 2005; 28: 1253-1259.
23 Centers f or Disease Control and Preventio n. Perceived i nsufficie nt rest or sleep
among ad ults — United States, 2005–2 008. MMWR 2011; 60: 239-242.
24 Hillman DR, Murphy AS, Antic R, Pezzullo L. The economic costs of sleep
disorders. Sleep 2006; 29: 299-305.
25 Deloitte Access Economics. Re-awakenin g Australia: the econ omic cost of
sleep disorders in Australia, 2010 . Canberra, Australia: Deloitte Access
Economics, 2011. http://www.sleephealthfoundat ion.org.au/pdfs/news/
Reawakening% 20Australia.p df (accesse d Jun 2013).
26 Ohayon MM, Caulet, M, Priest, RG, Guilleminault C. DSM-IV and ICSD-90
insomnia symptoms and sleep dissatisfaction. Br J Psy chiatry 1997; 171:
382-388.
... However, people who sleep less have more health threats (Buxton and Marcelli 2010;Hillman, and Lack 2013;Hafner et al. 2017;Mireku, and Rodriguez 2021), and lack of sleep has been linked to car accidents (Rosenstein 2008), among other things. Even though the economic cost of sleep disorders is significant (Hillman and Lack 2013), policymakers pay little attention to the importance of sleep (Basner, Spaeth, and Dinges 2014;Chaput and Dutil 2016). ...
... However, people who sleep less have more health threats (Buxton and Marcelli 2010;Hillman, and Lack 2013;Hafner et al. 2017;Mireku, and Rodriguez 2021), and lack of sleep has been linked to car accidents (Rosenstein 2008), among other things. Even though the economic cost of sleep disorders is significant (Hillman and Lack 2013), policymakers pay little attention to the importance of sleep (Basner, Spaeth, and Dinges 2014;Chaput and Dutil 2016). We join other researchers in calling for an awareness of sleep as an important policy consideration (Williams 2011;Hsu 2014). ...
... Given the established impact of the lack of sleep on health and the economic ramifications to societies (Hafner et al. 2017), we believe it is necessary to raise awareness of certain policies' side effects on sleep. Sleeping impacts health, productivity, and economic vitality (Chatzitheochari and Arber 2009;Buxton and Marcelli 2010;Hillman and Lack 2013;Hafner et al. 2017), and it is perceived as a human right (Williams 2011). While the Israeli public is not known to participate in policy processes (Vigoda-Gadot et al. 2014), future studies that reveal more details about policy effects and their link to the lack of sleep may inspire deliberation between policymakers and the public. ...
Article
Full-text available
Public policies aim to promote the social good, but they do not always meet this goal. We argue that to improve policy and policy analysis, it is important to pay attention to the cumulative effect of policies on how people use their time. In this study, we looked at the effect of certain policies on sleep. Our exploratory study yielded intriguing findings on sleep in Israel in the specific policy context of a dual burden of work and caregiving. We surveyed 671 participants on the effect of work and care hours on sleep. The findings showed participants slept an average of 6.6 hours and expressed the desire to sleep one hour more. The desire to sleep more was higher than for all other uses of time and was evident in all employment categories. Part-time workers slept more than full-time workers and women, and younger people asked to sleep more than older ones. Long work hours and care hours led to lower sleep hours. Our findings suggest the need to be aware of possible ‘side effects’ in the policy design stage and are relevant to other countries with a care-work burden.
... Further questions were derived from a number of sources including the United States National Sleep Foundation's 2002 Sleep in Adults survey 25 and previous Australian Sleep Health Foundation surveys. 24,26 Survey respondents were included in the analysis irrespective of work status/shift schedule, and a more detailed consideration of insomnia symptoms in shift workers from this sample has been previously reported. 27 ...
... 22 Not surprisingly, our findings vary significantly from an estimate of severe insomnia in another Australian study using sleep difficulties plus daytime impairment, which reported a prevalence of 8.7% in females and 5% in males. 26 However, severe insomnia symptoms ("trouble going to sleep or staying asleep?" experienced most or all of the time) have been frequently reported (17-25%) in large North American studies. 11,12 We observed similar rates of sleep initiation (15.5%) and maintenance difficulties (13.1-24%) experienced every/almost every night. ...
Article
Full-text available
Introduction: Estimating insomnia prevalence in epidemiological studies is hampered by variability in definitions and interpretation of criteria. We addressed the absence of a population-based estimate of insomnia in Australia using the widely accepted contemporary International Classification of Sleep Disorders (ICSD-3) criteria, which includes sleep opportunity, and has not been applied in studies to date. Consistent use of these criteria across epidemiological studies, however, requires evidence of the clinical utility of a sleep opportunity criterion for targeting strategies. Methods: A cross-sectional national on-line survey (2019 Sleep Health Foundation Insomnia Survey) of Australian adults (18-90 years, n = 2044) was conducted. Chronic insomnia was defined as sleep symptoms and daytime impairment experienced ≥3 times per week, and present for ≥3 months, with adequate sleep opportunity (time in bed (TIB) ≥7.5 hrs). Self-rated general health (SF-1) and ever diagnosed health conditions (including sleep disorders) were assessed. Results: Chronic difficulties initiating and maintaining sleep and daytime symptoms (n = 788) were more common in females (41.5%) than males (35.3%), p = 0.004. Excluding participants reporting frequent pain causing sleep disruption and TIB <7.5 hrs generated an insomnia disorder estimate of 25.2% (95% CI: 22.5-28.2) in females and 21.1% (18.4-23.9) in males [23.2% (21.2-25.2) overall]. This compares with 8.6% (7.3-10.0) with insomnia symptoms and TIB <7.5 hrs and 7.5% (6.4-8.7%) ever diagnosed with insomnia. Insomnia symptom groups with TIB <7.5 and ≥7.5 hours demonstrated similar odds of reporting fair/poor health [odds ratio (OR): 3.2 (95% CI: 2.1-4.8) and 2.9 (95% CI: 2.2-3.9) respectively], ≥1 mental health condition, ≥1 airway disease, and multimorbidity. Conclusion: Adults with significant sleep and daytime symptomatology and TIB <7.5 hrs did not differ clinically from those with insomnia disorder. Consideration of criteria, particularly adequate sleep opportunity, is required to consistently identify insomnia, and establish health correlates in future epidemiological studies. Further evaluation of the clinical utility of the sleep opportunity criterion is also required.
... 7.4 million Australian people report having ''inadequate" sleep [5], and 20%-35% are reported to have a diagnosed SD [6], associated with an annual cost to the Australian health system of Australian Dollar 66 billion [7]. SDs are an established risk factor for cardiovascular, psychiatric and cognitive health issues [3]. ...
... People with SDs had a high prevalence of chronic comorbid conditions, were predominantly older, and reported more financial difficulties than those without SDs [3]. This finding aligns with the sociodemographic profiles of people living with other chronic comorbid conditions globally [6]. Despite ''economic limitations," people with SDs reported higher use of CM than those without [3]. ...
Article
Objective To explore the difference in rates and reasons for disclosure of either conventional or complementary medicine (CM) to healthcare practitioners between people living with sleep disorders (SDs) and those without SDs. Methods A cross-sectional survey (N = 2019 adults) that measured sociodemographic characteristics, health status, health service utilisation, health literacy and health communication (medicine disclosure) of a representative sample of Australians was conducted. Data from participants reporting an SD (n = 265) were compared to those not reporting an SD to assess measures of health communication and disclosure about medicine use. Results Overall, rates of medicine disclosure to both conventional and CM practitioners were high, in respondents with (70%) and without an SD (57%). Those reporting an SD had higher expectations of their conventional health practitioner’s knowledge of CM, associated clinical decision-making skills, and approval of CM use, and held a higher degree of concern about drug interactions (P < 0.05). The main reasons cited for disclosing CM use to conventional health practitioners and conventional medicine use to CM practitioners were “I want them to fully understand my health status” and “I was concerned about drug interactions with the CMs used.” Conclusion The high rate of medicine use disclosure by people with SDs is driven by an intention to inform their healthcare practitioner about their health status and concerns about potential medicine interactions. Therefore, research about the expectations that people with an SD have of their conventional healthcare practitioners’ knowledge of CM and CM-drug interactions requires further examination. Likewise, further examination of CM practitioner’s conventional medicine knowledge is encouraged.
... 7,8 Insufficient sleep not only impacts at a personal level, but also can cause major impact on a larger scale through a high burden of non-communicable diseases, 12 many events such as motor vehicle crashes, 13 workplace accidents, increased mortality and reduced quality of life. 14 Media use such as watching TV and using electronic devices are activities that cause PSQ among children and adolescents. Especially among school age group, having a TV in the bedroom can disturb sleep resulting in decreased sleep duration and insufficient sleep. ...
Article
Background : Poor sleep quality (PSQ) is an increasing health problem among adolescents. Mobile phones and portable media devices have become a part of children’s lives and may affect their sleep duration and quality. This study aimed to explore the prevalence of PSQ and identify the association between media use and PSQ among adolescents studying in high school grades 10-12. Methods: This cross-sectional study was conducted in central Thailand. A multi-stage sampling technique was used to enroll 777 adolescents from eight schools from August to October 2016. The research instruments comprised factors of demographics and consumption behaviors and the Pittsburgh Sleep Quality Index questionnaire. Multivariable logistic regression was used to calculate adjusted odds ratios (OR adj ) and 95% confidence intervals (CI). Results: Prevalence of PSQ was 56.24%. The study subjects were mostly 16-17 years old (67.82%) and female (70.39%). Multivariable logistic regression, after controlling for possible confounders, revealed an increased odds of PSQ among those who used a social media device (OR=1.34, 95%CI=0.97-1.87), and showed a higher proportion of social media use in the PSQ group. Conclusion: A surveillance system to detect media use and PSQ should be conducted accompanied by knowledge sharing on media use among parents, teachers and adolescents. To determine causal relationships, further longitudinal studies will be required to test the association between media users and PSQ. This study may also provide some implications for health promotion on sleep quality of senior high school students.
... Sleep disorders, poor sleep quality, and abnormal sleep duration are prevalent issues affecting >20% to 30% of the Western population 1 . Insomnia, defined as a complaint of trouble initiating or maintaining sleep associated with daytime consequences and not attributable to environment circumstances or inadequate opportunity to sleep, is the most common sleep disorder, being more prevalent in females and increasing with age 2 . ...
Article
: Sleep disturbances can increase the risk of falls and motor vehicle accidents and may reduce bone density. ➤: Poor sleep can lead to worse outcomes after fracture, such as chronic pain and delayed recovery. ➤: Orthopaedic surgeons can play an important role in the screening of sleep disorders among their patients.
... Sleep deprivation (SD) due to modern lifestyle, work schedules, social and psychological stress results in physical and mental health problems which have placed a huge financial burden on global economy (Hillman & Lack, 2013). Sleep plays a critical role in maintaining metabolic homeostasis, memory consolidation, neuronal reactivation, and learning (Stickgold & Walker, 2005). ...
Article
Full-text available
Sleep deprivation due to present-day lifestyle and late-hours work commitments are associated with a broad spectrum of neurobehavioral complications. Moreover, women, as they age, become prone to the cumulative effects of menopause such as sleep disturbances, adiposity, and inflammation which are attributed to a compromised immuno-neuro-endocrine axis. So far, no effective therapeutic remedy is available to mitigate the adverse effects of SD. The current study was aimed to elucidate the neuroprotective potential of n-Butanol fraction obtained from hydroalcoholic extract of Tinospora cordifolia stem (B-TCE). Four groups of female rats are (1) Vehicle-undisturbed sleep, (2) Vehicle-sleep deprived (between 6 a.m. and 6 p.m.), (3) B-TCE oral feeding for 2 weeks and sleep deprivation, and (4) B-TCE alone undisturbed sleep group. Novel Object Recognition test was used to study cognitive impairments and Rotarod for motor coordination. Rats were then sacrificed to study the expression of various marker proteins in the hippocampus and piriform cortex regions of the brain by western blotting. SD was observed to impair the exploratory behavior and neuromuscular coordination, whereas, B-TCE pre-treatment was observed to ameliorate these behavioral functions’- impairments and further suppressed the changes in the expression of markers for synaptic plasticity, inflammation, cell survival, and apoptosis pathways. The current data suggest that B-TCE may be effective in the management of acute SD-associated impairments in learning and memory functions and neuromuscular coordination.
... Sleep disorders negatively affect the person's mental, cognitive, and psychomotor state throughout the day. The person is less productive in their daily life due to tiredness and attention deficit, thus creating a serious health problem (21). On the other hand, psychological factors such as anxiety and depression also cause sleep disorders. ...
Article
Objective:The objective of the study is to investigate sleep disorders in patients with polycystic ovary syndrome (PCOS) and determine the relationship of sleep disorders with the metabolic and psychogenic aspects of PCOS.Materials and Methods:This case-control study was conducted between October 1, 2019, and March 1, 2020, at the gynaecology and neurology outpatient clinics of a tertiary hospital. The study included 73 patients diagnosed with PCOS and 63 healthy women volunteers. Testosterone, fasting glucose and fasting insulin levels of all the participants were measured. All study participants completed Beck’s depression inventory (BDI), Beck’s anxiety inventory (BAI), Epworth Sleepiness scale (ESS), Berlin questionnaire (BQ), insomnia severity index (ISI), and Pittsburgh sleep quality index (PSQI). The presence of restless legs syndrome (RLS) was assessed according to the international RLS study group criteria.Results:According to PSQI scores, 61.6% of patients with PCOS and 34.9% of healthy controls had a poor sleep quality (p=0.003). The PCOS group had significantly higher PSQI, ESS, ISI, BAI, BDI, and BQ scores than the control group (p=0.002, p=0.001, p
... Relative to non-sleep disordered controls, individuals with insomnia report greater healthcare usage in inpatient, emergency department and outpatient settings, as well as prescription fills (8). In Australia, the estimated economic cost of sleep disorders is $5.1 billion per year, of which $540 million is due to associated co-occurring medical conditions (9). The financial burden of insomnia is ubiquitous, with similar trends observed across Europe and North America (10). ...
Article
Insomnia is a chronic condition and major healthcare problem for Australians across the lifespan. Insomnia’s high prevalence and disease burden render it an important target for treatment. Further, and importantly, there exist established bidirectional links between insomnia and a range of health conditions, with insomnia both contributing to risk, maintenance and relapse of comorbid conditions. Recent clinical research demonstrates that treating insomnia in its own right is important for resolution of insomnia and for optimising treatment outcomes for comorbid presenting problems. Due to its effectiveness and favourable side-effect profile, Cognitive Behaviour Therapy-Insomnia (CBT-I) is the recommended first line treatment even when comorbid conditions are present. CBT-I is a brief treatment often delivered in 4-8 consultations. Individual, group and online CBT-I each have each demonstrated effectiveness. Outcomes for online CBT-I are often stronger when individualised clinician support is provided. Specifically assessing for and treating insomnia in clinical practice may provide an opportunity to optimise treatment outcome in many patients.
Article
Issue addressed: Insufficient sleep and unhealthy sleep practices in adolescents are associated with significant health risks. Sleep education programs in schools aim to improve sleep behaviour. A new eLearning sleep education program, Healthy Sleep for Healthy Schools (HS4HS), was developed focused on these goals and is distinguishable from other sleep education programs because it is delivered by teachers, making it more sustainable and adaptable for schools. We aimed to evaluate if HS4HS would improve student sleep knowledge, healthy sleep practices, sleep duration and reduce sleepiness. We also aimed to understand if this intervention could be successfully implemented by trained teachers. Methods: Teachers trained in sleep delivered HS4HS to 64 South Australian students in year 9 (aged 13-14 years) over 6 weeks during regular school curriculum. A sleep education survey assessing sleep patterns (such as healthy sleep practices, time in bed and sleepiness), and a sleep knowledge questionnaire was completed pre and post HS4HS delivery. Evaluations were also completed by teachers. Results: Sleep knowledge and healthy sleep practices significantly improved post intervention. Time in bed on both school days and weekends increased slightly and sleepiness decreased slightly but these changes were not statistically significant. Teachers found the program useful, comprehensive and easy to incorporate into their curricula. Conclusions: After short training, teachers can deliver sleep education during class and improve sleep practices in their students. This suggests that this program may offer potential as an effective and useful resource for teachers wanting to include sleep health in their curriculum. SO WHAT?: Sleep is the foundation of good health and teachers can promote and integrate sleep education into their curricula for the first time with this online teacher focussed program which has the potential to be a sustainable sleep health promotion resource.
Article
Citation: Sleep is a biological necessity, and insufficient sleep and untreated sleep disorders are detrimental for health, well-being, and public safety. Healthy People 2030 includes several sleep-related objectives with the goal to improve health, productivity, well-being, quality of life, and safety by helping people get enough sleep. In addition to adequate sleep duration, healthy sleep requires good quality, appropriate timing, regularity, and the absence of sleep disorders. It is the position of the American Academy of Sleep Medicine (AASM) that sleep is essential to health. There is a significant need for greater emphasis on sleep health in education, clinical practice, inpatient and long-term care, public health promotion, and the workplace. More sleep and circadian research is needed to further elucidate the importance of sleep for public health and the contributions of insufficient sleep to health disparities. Citation: Ramar K, Malhotra RK, Carden KA, et al. Sleep is essential to health: an American Academy of Sleep Medicine position statement. J Clin Sleep Med. 2021;17(10):2115-2119.
Article
Full-text available
Previous studies have shown that both short and long sleep durations are related to increased likelihood of diabetes and hypertension. However, the relation between sleep duration and cardiovascular disease (CVD) is not clear. We examined the hypothesis that compared with sleep duration of 7 hours, shorter and longer sleep durations are independently related to CVD. We conducted a cross-sectional study of 30,397 National Health Interview Survey 2005 participants > or = 18 years of age (57.1% women). Sleep duration was categorized as < or = 5 hours, 6 hours, 7 hours, 8 hours, and > or = 9 hours. The main outcome of interest was the presence of any CVD (n = 2146), including myocardial infarction, angina, and stroke. We found both short and long sleep durations to be independently associated with CVD, independent of age, sex, race-ethnicity, smoking, alcohol intake, body mass index, physical activity, diabetes mellitus, hypertension, and depression. Compared with a sleep duration of 7 h (referent), the multivariate odds ratio (95% confidence interval) of CVD was 2.20 (1.78, 2.71), 1.33 (1.13, 1.57), 1.23 (1.06, 1.41), and 1.57 (1.31, 1.89) for sleep duration < or = 5 h, 6 h, 8 h, and > or = 9 h. This association persisted in subgroup analyses by gender, race-ethnicity, and body mass index categories. Also, similar associations were observed when we examined myocardial infarction and stroke separately. Compared with sleep duration of 7 h, there was a positive association between both shorter and longer sleep durations and CVD in a representative sample of US adults. These results suggest that sleep duration may be an important marker of CVD.
Article
Full-text available
To examine the joint effect of insomnia and objective short sleep duration on hypertension risk. Representative cross-sectional study. Sleep laboratory. 1,741 men and women randomly selected from central Pennsylvania. None. Insomnia was defined by a complaint of insomnia with a duration > or = 1 year, while poor sleep was defined as a complaint of difficulty falling asleep, staying asleep, or early final awakening. Polysomnographic sleep duration was classified into 3 categories: > or = 6 h sleep (top 50% of the sample); 5-6 h (approximately the third quartile of the sample); and < or = 5 h (approximately the bottom quartile of the sample). Hypertension was defined based either on blood pressure measures or treatment. We controlled for age, race, sex, body mass index, diabetes, smoking, alcohol use, depression, sleep disordered breathing (SDB), and sampling weight. Compared to the normal sleeping and > 6 h sleep duration group, the highest risk of hypertension was in insomnia with < 5 h sleep duration group (OR [95% CI] 5.1 [2.2, 11.8]), and the second highest in insomnia who slept 5-6 hours (OR 3.5 [1.6, 7.9] P < 0.01). The risk for hypertension was significantly higher, but of lesser magnitude, in poor sleepers with short sleep duration. Insomnia with short sleep duration is associated with increased risk of hypertension, to a degree comparable to that of other common sleep disorders, e.g., SDB. Objective sleep duration may predict the severity of chronic insomnia a prevalent condition whose medical impact has been apparently underestimated.
Article
Full-text available
Sleep duration is associated with cardiovascular disease and diabetes risk factors, depression, automobile and workplace accidents, and prospective mortality. Little is known, however, about sleep patterns in the US population. The 2004-2007 National Health Interview Survey-Sample Adult Files provide nationally representative data for 110,441 noninstitutionalized US adults aged 18 years or older, and multinomial logistic regression examines whether variables in 5 domains-demographic, family structure, socioeconomic, health behavior, and health status-are associated with long or short sleep duration. Being older, non-Hispanic black, or a current or former smoker; having low levels of education, income, or few income sources; consuming few or numerous drinks in a week; or reporting cardiovascular disease, diabetes, depression, underweight, or activity limitations is associated with increased odds of both long and short sleep duration. Other variables are associated with shorter (e.g., living with young children, being unmarried, working long hours, more frequent binge drinking) or longer (e.g., being younger, Mexican American, pregnant, or having low levels of physical activity) sleep hours. The authors identify numerous risk factors for long and short sleep; many of those variables are potential confounders of the relation between sleep hours and other health outcomes.
Article
To determine whether a cumulative sleep debt (in a range commonly experienced) would result in cumulative changes in measures of waking neurobehavioral alertness, 16 healthy young adults had their sleep restricted to an average 4.98 hrs per night for 7 consecutive nights. Ss slept in the laboratory, and sleep and waking were monitored. Three times each day, Ss were assessed for subjective sleepiness and mood and were evaluated on a brief performance battery that included psychomotor vigilance (PVT), probed memory (PRM), and serial-addition testing. Once each day they completed a series of visual analog scales (VASs) and reported sleepiness and somatic and cognitive/emotional problems. Sleep restriction resulted in statistically robust cumulative effects on waking functions. Subjective sleepiness ratings, subscale scores for fatigue, confusion, tension, and total mood disturbance from the mood and VAS ratings of mental exhaustion and stress were elevated across days of restricted sleep. PVT performance parameters were also significantly increased by restriction. Significant time-of-day effects were evident in subjective sleepiness and PVT data. Findings suggest that cumulative nocturnal sleep debt had a dynamic and escalating analog in cumulative daytime sleepiness and that asymptotic or steady-state sleepiness was not achieved in response to sleep restriction. (PsycINFO Database Record (c) 2012 APA, all rights reserved)
Article
Objective: To determine the extent to which insomnia poses an independent burden on individual function and healthcare use in Australia. Methods: Cross-sectional data from 8,841 respondents and representative of the Australian population aged 16 to 85 in the 2007 National Mental Health and Wellbeing Survey were analysed. Insomnia was defined as ‘sleeping only in short bursts and being awake most of the night’ during the past week. This measure was validated against common epidemiological indicators of insomnia. Associations between insomnia, disability and healthcare consumption were explored using multivariate logistic regression. Results: Insomnia was reported by 5.6% of adults and was associated with older age, female gender, pain and psychological distress. Controlling for these and other a priori confounders, insomnia was associated with greater odds of (Adjusted Odds Ratio; 95% CI): disability days (1.62; 1.20–2.18), difficulties in daily activities (1.60; 1.10–2.31), life dissatisfaction (2.34; 1.11–4.93), use of sleep medication (1.78; 1.12–2.82) and a higher number of visits to general practitioners (1.57; 1.06–2.33). Insomnia was not significantly associated with the use of medications for mental health (1.17; 0.82–1.67), hospital admissions (1.31; 0.82–1.67), the use of complementary and alternative medicine (1.10; 0.73–1.67) or unmet need for healthcare (1.22; 0.84–1.77). Conclusions: One in twenty adult Australians experience a level of insomnia that is independently associated with impairments in functioning and increased use of healthcare. Implications: Increasing public and clinician awareness of the impact of insomnia, and promotion of available insomnia treatments may be warranted.
Article
Obstructive sleep apnea (OSA) is gaining recognition as a cardiovascular and cerebrovascular risk factor. Sleep apnea is now implicated in the etiopathogenesis of stroke, coronary artery disease, hypertension, and congestive heart failure. OSA exerts its negative cardiovascular consequences through its unique pattern of intermittent hypoxia and arousals. The putative mechanisms involved in the pathogenesis of cardiovascular disease in OSA include fibrinolytic imbalance, endothelial dysfunction, oxidative stress, and inflammation. This study discusses the known cellular and molecular processes that promote atherogenesis and vascular dysfunction in patients with OSA, and their implications for cardiovascular disease and prevention in that patient population. Neurologists should familiarize themselves with the symptoms and signs of OSA and the pathophysiology of the association between untreated OSA and cardiovascular disease, including stroke. OSA should be ruled out in patients with cardiovascular disease and be regarded as an important modifiable risk factor. Knowledge of this association is of prime public health importance and can result in primary and secondary prevention of cardiovascular events. This study will also help neurologists in providing patient education and treatment.
Article
To investigate the association between short sleep duration and elevated body mass index (BMI) and obesity in a large sample of Japanese adults over a short period. Prospective design with baseline in 2006 and 1-year follow-up. Workplaces of an electric power company in Japan. 35,247 company employees (31,477 men, 3,770 women) distributed throughout Japan. Measured weight and height and self-reported sleep duration were obtained at annual health checkup in 2006 and 2007. Weight change was defined as the difference in body mass index (BMI) between the baseline and 1 year later. Relative to the reference category (sleep duration 7-8 h), short sleep duration (< 5 and 5-6 h) and long sleep duration > or = 9 h were associated with an increased risk of weight gain among men after adjustment for covariates. Of the non-obese (BMI < 25) men at baseline, 5.8% became obese (BMI > or = 25) 1 year later. Higher incidence of obesity was observed among the groups with shorter sleep duration. Adjusted odds ratios for the development of obesity were 1.91 (95% CI 1.36, 2.67) and 1.50 (95% CI 1.24, 1.80) in men who slept < 5 and 5-6 h, respectively. No significant association between sleep duration and weight gain or obesity was found for women. Short sleep duration was associated with weight gain and the development of obesity over 1 year in men, but not in women.
Article
This review of the scientific literature examines the widely observed relationship between sleep duration and mortality. As early as 1964, data have shown that 7-h sleepers experience the lowest risks for all-cause mortality, whereas those at the shortest and longest sleep durations have significantly higher mortality risks. Numerous follow-up studies from around the world (e.g., Japan, Israel, Sweden, Finland, the United Kingdom) show similar relationships. We discuss possible mechanisms, including cardiovascular disease, obesity, physiologic stress, immunity, and socioeconomic status. We put forth a social-ecological framework to explore five possible pathways for the relationship between sleep duration and mortality, and we conclude with a four-point agenda for future research.